Diagnosing and treating brain tumors in children
There are many types and subtypes of brain tumors in children, and heterogeneity is common among tumors with similar morphology, according to Mustafa Barbour, M.D., pediatric hematologist/oncologist at Norton Children’s Cancer Institute, affiliated with the [...]
View more
The acute lymphoblastic leukemia link to obesity
Survivors of the most common childhood cancer, acute lymphoblastic leukemia (ALL), need long-term monitoring for obesity and other ongoing health consequences of their disease and treatment. “The etiology of obesity among ALL survivors is not […]
View more
Burkitt lymphoma, one of the more common forms of non-Hodgkin lymphoma, has a variety of clinical presentations
Burkitt lymphoma, an aggressive subtype of non-Hodgkin lymphoma (NHL), accounts for 40% of all NHL cases in the United States. This high-grade, fast-growing form of lymphoma starts in the immune system’s B cells and has […]
View more
Immunotherapy for refractory B-cell acute lymphoblastic leukemia
The five-year survival rate for children and adolescents with acute lymphoblastic leukemia (ALL) has reached about 90% with chemotherapy. Clinicians increasingly are turning to immunotherapy for relapsed/refractory B-cell ALL (B-ALL). Immunotherapy harnesses the innate power [...]
View more
Don’t overlook these signs and symptoms of leukemia in children
Pediatricians can help with early detection of childhood leukemia during routine visits. Even though a patient’s signs and symptoms may appear vague, mild or suggestive of more common health conditions, they shouldn’t be ignored. In […]
View more
Reduced-toxicity myeloablative conditioning regimen effective against high-risk pediatric leukemias
A low-toxicity myeloablative conditioning regimen is safe and effective in treating high-risk leukemias, particularly myeloid disease, according to a study recently published in the journal Pediatric Blood & Cancer. Conventional myeloablative conditioning is effective at […]
View more
Offering the latest childhood brain tumor therapies so kids and their families don’t have to travel far from home
Brain tumors are now the leading cause of cancer-related deaths among children. Year after year, Kentucky ranks among states with the highest incidence of children with brain tumors, and Kentucky currently ranks third in the [...]
View more
Optimizing leukemia/lymphoma care with a multidisciplinary team
The most effective way to optimize patient care revolves around a combination of physicians, nurses, pharmacists, nurse practitioners, social workers and case managers. Members of the team work together to help with decision-making in each […]
View more
Access to evolving clinical science close to home
Norton Cancer Institute’s clinical research program was developed to ensure that cancer patients in our community and region have access to evolving clinical science. Guided by an experienced cadre of physicians and supported by a […]
View more
Groundbreaking research and exceptional care come with Norton Children’s Cancer Institute/UofL School of Medicine affiliation
This is an exciting time for Norton Children’s Cancer Institute, affiliated with the UofL School of Medicine. The clinical-academic partnership for all pediatric hematology/oncology inpatient, outpatient and pediatric infusion care provides more integrated care options, […]
View more
Pediatric oncology case study: Rotationplasty aids osteosarcoma recovery
The patient A 12-year-old female presented to Norton Children’s Hospital emergency department with a one-week history of worsening right knee pain and swelling. There was no known trauma, but pain started after exertion in gym […]
View more
The latest advancements in pediatric cancer research for patients in Louisville and Southern Indiana
At any time, Norton Children’s Cancer Institute, affiliated with the UofL School of Medicine, is participating in dozens of clinical trials, representing a wide gamut of diagnoses and moving our understanding of childhood cancers forward. […]
View more